Filtros de búsqueda

Lista de obras de Li-Chun Lu

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma

artículo científico publicado en 2021

Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy

artículo científico publicado en 2014

Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma

artículo científico publicado en 2019

Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.

artículo científico publicado en 2012

Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment

scientific article published on 15 June 2018

Increasing Incidence of Brain Metastasis in Patients with Advanced Hepatocellular Carcinoma in the Era of Antiangiogenic Targeted Therapy ⬇️

artículo científico publicado el 6 de enero de 2011

Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma

artículo científico publicado en 2016

Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer

artículo científico publicado en 2012

Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study

artículo científico publicado en 2017

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.

artículo científico publicado en 2012

Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy

artículo científico publicado en 2013

Recent advances in the prevention of hepatocellular carcinoma recurrence

artículo científico publicado en 2014

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives

artículo científico publicado en 2019

Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma

artículo científico publicado en 2017

Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials

artículo científico publicado en 2015

Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges

artículo científico publicado en 2016

β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda